Open Accessibility Menu

Clinical Trial Information

BioSET Prefix Study

Study Details

This study is designed to evaluate the safety and preliminary effectiveness of one coating concentration of Prefix compared to iliac crest bone in approximately 22 skeletally mature subjects diagnosed with degenerative disc disease (DDD) at one vertebral level (L2-S1).

Primary Sponsor:

Biosurface Engineering Technologies, Inc. (BioSET)

Prinicipal Investigator:

Joseph O'Brien MD

Interested in More Information

  • Please enter your first name.
  • Please enter your last name.
  • This isn't a valid email address.
    Please enter your email address.
  • This isn't a valid phone number.
    Please enter your phone number.
    You entered an invalid number.
  • Please enter your address.
  • Please enter your city.
  • Please enter your state.
  • Please enter your zip code.
  • (All Uppercase. No Spaces)